Migraine drug makes people have fewer 'migraine days’

Getty By New Scientist staff and Press Association A drug can halve the amount of time that people are laid low by migraines. Erenumab is an antibody that blocks a brain pathway involving a molecule called CGRP, which becomes more abundant during migraine attacks. In a trial of nearly 1,000 people,
  • 首页
  • 游艇租赁
  • 电话
  • 关于我们